Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruben J Boado

Showing results (41-50 of 97) with videos related to

Pageof 10
Sort By:
Molecular Pharmaceutics|May 13, 2009
IgG-paraoxonase-1 fusion protein for targeted drug delivery across the human blood-brain barrierRuben J Boado, Yun Zhang, Yufeng Zhang, et al.
Neuroreport|October 10, 2003
The Ro52/SS-A autoantigen has elevated expression at the brain microvasculatureEric V Shusta, Jian Yi Li, Ruben J Boado, et al.
Biotechnology and Bioengineering|December 15, 2007
GDNF fusion protein for targeted-drug delivery across the human blood-brain barrierRuben J Boado, Yun Zhang, Yufeng Zhang, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 14, 2002
Vascular genomics of the human brainEric V Shusta, Ruben J Boado, Gary W Mathern, et al.
Human Gene Therapy|February 8, 2003
Intravenous nonviral gene therapy causes normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonismYun Zhang, Frederic Calon, Chunni Zhu, et al.
Biotechnology and Bioengineering|August 31, 2010
CHO cell expression, long-term stability, and primate pharmacokinetics and brain uptake of an IgG-paroxonase-1 fusion proteinRuben J Boado, Eric Ka-Wai Hui, Jeff Zhiqiang Lu, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 18, 2010
Drug targeting of erythropoietin across the primate blood-brain barrier with an IgG molecular Trojan horseRuben J Boado, Eric Ka-Wai Hui, Jeff Zhiqiang Lu, et al.
Human Gene Therapy|April 1, 2004
Normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism with intravenous nonviral gene therapy and a brain-specific promoterYun Zhang, Felix Schlachetzki, Yu-Feng Zhang, et al.
Biotechnology and Bioengineering|October 10, 2009
IgG-single chain Fv fusion protein therapeutic for Alzheimer's disease: Expression in CHO cells and pharmacokinetics and brain delivery in the rhesus monkeyRuben J Boado, Jeff Zhiqiang Lu, Eric Ka-Wai Hui, et al.
The Journal of Gene Medicine|December 19, 2007
Intravenous glial-derived neurotrophic factor gene therapy of experimental Parkinson's disease with Trojan horse liposomes and a tyrosine hydroxylase promoterChun-Fang Xia, Ruben J Boado, Yun Zhang, et al.
Pageof 10

Showing results (41-50 of 97) with videos related to

Sort By:
Pageof 10
Molecular Pharmaceutics|May 13, 2009
IgG-paraoxonase-1 fusion protein for targeted drug delivery across the human blood-brain barrierRuben J Boado, Yun Zhang, Yufeng Zhang, et al.
Neuroreport|October 10, 2003
The Ro52/SS-A autoantigen has elevated expression at the brain microvasculatureEric V Shusta, Jian Yi Li, Ruben J Boado, et al.
Biotechnology and Bioengineering|December 15, 2007
GDNF fusion protein for targeted-drug delivery across the human blood-brain barrierRuben J Boado, Yun Zhang, Yufeng Zhang, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 14, 2002
Vascular genomics of the human brainEric V Shusta, Ruben J Boado, Gary W Mathern, et al.
Human Gene Therapy|February 8, 2003
Intravenous nonviral gene therapy causes normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonismYun Zhang, Frederic Calon, Chunni Zhu, et al.
Biotechnology and Bioengineering|August 31, 2010
CHO cell expression, long-term stability, and primate pharmacokinetics and brain uptake of an IgG-paroxonase-1 fusion proteinRuben J Boado, Eric Ka-Wai Hui, Jeff Zhiqiang Lu, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 18, 2010
Drug targeting of erythropoietin across the primate blood-brain barrier with an IgG molecular Trojan horseRuben J Boado, Eric Ka-Wai Hui, Jeff Zhiqiang Lu, et al.
Human Gene Therapy|April 1, 2004
Normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism with intravenous nonviral gene therapy and a brain-specific promoterYun Zhang, Felix Schlachetzki, Yu-Feng Zhang, et al.
Biotechnology and Bioengineering|October 10, 2009
IgG-single chain Fv fusion protein therapeutic for Alzheimer's disease: Expression in CHO cells and pharmacokinetics and brain delivery in the rhesus monkeyRuben J Boado, Jeff Zhiqiang Lu, Eric Ka-Wai Hui, et al.
The Journal of Gene Medicine|December 19, 2007
Intravenous glial-derived neurotrophic factor gene therapy of experimental Parkinson's disease with Trojan horse liposomes and a tyrosine hydroxylase promoterChun-Fang Xia, Ruben J Boado, Yun Zhang, et al.
Pageof 10